Diligence memo · auto-generated · as of July 2, 2026
Encore Dermatology, Inc.
Encore Dermatology, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Encore Dermatology, Inc. operates in Other Health Care, based in MALVERN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Encore Dermatology, Inc. has raised $90M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $34M on 2018-01-04.
Most recent recorded round closed around 2019-04-01.
Valuation (modeled)modeled
Provath models Encore Dermatology, Inc. at approximately $730M (range $77M–$2.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.95× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 7.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 95% of Other Health Care peers (5377 compared).
Modeled value ranks above 95% of those peers.
Closest niche peers: KSMS Holdings, LLC, Infab HoldCo, Inc., Aquity Holdings, Inc., MHH Management Holdco, LLC, Earli Inc..
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.